UCB PHARMA AKTIEBOLAG (SWEDEN)
Global biopharma leader creating solutions for severe neurological diseases.
Oversigt
- 20–49
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 1972
- Grundlagt
Nøglebeslutningstagere
Werner Bleilevens
Head of Communications
Nils Meier
Asset Communications Lead
Dr Karl-Werner Leffers
General Manager Germany
Emmanuel Caeymaex
Executive Vice President Patient Evidence
+29 flere kontakter i Funnelfeedr
Beskrivelse
UCB is a global biopharmaceutical leader dedicated to improving the lives of people living with severe diseases. The organization focuses intensely on developing valuable solutions for neurological and autoimmune conditions. With a workforce exceeding 9,000 people across nearly 40 countries, UCB dri...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Partihandel med medicinsk utrustning och apoteksvaror
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556071118501
Beslutningstagere
33 kontakter i FunnelfeedrWerner Bleilevens
Head of Communications
Nils Meier
Asset Communications Lead
Dr Karl-Werner Leffers
General Manager Germany
Emmanuel Caeymaex
Executive Vice President Patient Evidence
Donatello Crocetta
Chief Medical Officer
Sandrine Dufour
Executive Vice President Chief Financial Officer
Alistair Henry
Executive Vice President Chief Scientific Officer
Jean-Luc Fleurial
Executive Vice President & Chief Human Resources Officer
Jean-Christophe Tellier
CEO
Kirsten Lund-Jurgensen
Executive Vice President, Patient Supply
Denelle Waynick Johnson
Executive Vice-President & General Counsel
Fiona du Monceau
Executive Vice President Chief Commercial Officer
Julia Schenk
Corporate Communications Lead
Erica Puntel
US Communications
Francesco Ricca
Italy Communications
Diyana Mishu
Investor Relations Manager
Thomas Lhernould
France Communications
Andre kontakter
Nick Francis
Patient Impact and Neurology Communications
Patrice Scherly
Site Contact Person
Antje Witte
Investor Relations
Sahar Yazdian
Investor Relations
+12 flere kontakter i Funnelfeedr
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
AbbVie AB
100–199 medarbejdereAbbVie discovers and develops innovative medicines for serious diseases globally.
NOVARTIS SVERIGE AKTIEBOLAG
100–199 medarbejdereGlobal innovative medicines company improving and extending people’s lives.
ABBVIE AS
71 medarbejdereGlobal biopharmaceutical company discovering and delivering innovative medicines.
Merck Aktiebolag
20–49 medarbejdereResearch-intensive biopharmaceutical company developing human and animal health solutions.
Santhera Pharmaceuticals (Sweden) AB
1–4 medarbejdereSwiss specialty pharma developing treatments for rare neuromuscular diseases.
Udforsk mere
Spørgsmål om UCB PHARMA AKTIEBOLAG (SWEDEN)
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo